AKT1 and lung carcinoma: We report here that BGM can significantly inhibit TGF-β-induced EMT and invasive capability of lung cancer cells, and the mechanism underlying these effects can correlate to its ability to abrogate the activation of PI3K/Akt/mTOR kinases.